Coronavirus company news summary – Applied DNA Sciences establishes subsidiary for Covid-19 tests – Royal Philips launches 3D facial scanning solution for mask selection

10 July 2020 (Last Updated July 10th, 2020 09:28)

Applied DNA Sciences has formed a subsidiary named Applied DNA Clinical Labs, which will develop tests for the detection of Covid-19. The newly formed subsidiary will also explore development of test for detection of invasive Circulating Tumor Cells (iCTCs). The company plans to increase its market reach with the development of value-added services in addition to the portfolio of diagnostic assays.

Royal Philips has launched the Philips Respironics Mask Selector, a clinically validated, 3D facial scanning solution that helps providers to fit nine out of ten patients with the right mask. The Mask Selector algorithm is expected to aid in improving efficiency of businesses by decreasing the costs related to fitting time and waste of masks.

EpiGentek has released a series of SARS-CoV-2 research assays to aid in the fight against the ongoing global Covid-19 pandemic. The two kits focus on studies of SARS-CoV-2 targeted furin or proprotein convertase (PC) cleavage activity. The tools are expected to detect SARS-CoV-2 targeted PC and facilitated proteases with biological samples. They can also screen for these enzyme inhibitors.

Chapters Health Foundation has secured funding to procure 2,000 personal protective equipment (PPE) kits with the help of a $50,000 grant from Regions Bank. The kit is made of one N95 mask, isolation mask, disposable isolation gown, shoe covers, cap, face shield and disposable gloves. These kits are expected to aid its team members, patients and families.